PRIMARY STUDY
Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study
Key Findings: This study assessed the effects of cannabidiol-rich cannabis given to children and adolescents with autism spectrum disorder (ASD) and found that overall there were significant improvements in their social communication skills.
Type of Study: Clinical Trial
Study Sample Size: 82
Study Result: Positive
Study Location(s): Israel
Year of Pub: 2022
Cannabinoids Studied: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Anandamide (AEA), 2-Arachidonoyl Glycerol (2-AG), Pharma THC:CBD
Phytocannabinoid Source: Cannabis Flower derived
Chemotype: Chemotype III
Sub-Ratio: THC:CBD 1:20
Dosage: 0.3 mg THC:5.7 mg CBD per drop CBD up to 10 mg/kg/day (or total of 400 mg/day) THC up to 0.5 mg/kg/day (or total of 20 mg/day)
Route of Administration: Oral (Ingestion)
Link to study
